Hibiscus Sabdariffa + Erdafitinib
Erdafitinib brand name: Balversa.
Erdafitinib falls into 2 drug categories that Hibiscus Sabdariffa can interact with; the most serious is rated minor. Theoretically, Hibiscus sabdariffa extract might reduce the metabolism of CYP2C9 substrates.
Read the full interaction reportHibiscus Sabdariffa and Erdafitinib
These two interact in 2 distinct ways. Each one is explained separately below.
Why Are There 2 Interactions?
Hibiscus Sabdariffa interacts with whole categories of medication. Erdafitinib falls into 2 of those categories, so it can interact with Hibiscus Sabdariffa in 2 different ways. We’ve listed each one below — your overall risk is driven by the most serious of them (Minor).
CYTOCHROME P450 2C9 (CYP2C9) SUBSTRATES
1 of 2Why this applies to Erdafitinib
Erdafitinib falls under CYTOCHROME P450 2C9 (CYP2C9) SUBSTRATES — the group Hibiscus Sabdariffa interacts with.
In vitro research shows that Hibiscus sabdariffa calyx extract inhibits CYP2C9. This interaction has not been reported in humans.
Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
Here's the simple version. Erdafitinib (Balversa) is partly cleared by a liver enzyme called CYP2C9. In the lab, concentrated hibiscus extract seems to slow that enzyme down a bit. If that happened in your body, erdafitinib could clear a little more slowly and build up, which in theory might nudge up side effects like dry mouth and eyes, mouth sores, high phosphate levels, vision or nail changes, and diarrhea.
The important thing: this is only a theoretical, test-tube finding and has not been seen in real patients, so it's rated minor. A cup of tart hibiscus tea is unlikely to matter, while strong supplement doses are the bigger question mark. Since erdafitinib is a serious cancer drug, please run any hibiscus supplement past your oncology team first.
- Johnson SS, Oyelola FT, Ari T, Juho H. In vitro inhibitory activities of the extract of Hibiscus sabdariffa L. (family Malvaceae) on selected cytochrome P450 isoforms. Afr J Tradit Complement Altern Med. 2013 Apr 12;10(3):533-40.
CYTOCHROME P450 3A4 (CYP3A4) SUBSTRATES
2 of 2Erdafitinib also falls under CYTOCHROME P450 3A4 (CYP3A4) SUBSTRATES.
In vitro research shows that Hibiscus sabdariffa calyx extract inhibits CYP3A4. This interaction has not been reported in humans.
Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
Here's the gist for hibiscus and your erdafitinib (Balversa). Your body clears erdafitinib using a liver enzyme called CYP3A4. In a lab dish, concentrated hibiscus calyx extract slowed that enzyme down a bit. If that happened in your body, erdafitinib could clear more slowly and build up, which might mean more of its usual side effects, like dry mouth and eyes, mouth sores, changes in your nails or skin, or shifts in your phosphate levels.
That said, this is purely theoretical. It has only been seen in test tubes, not in real people, and a cup of hibiscus tea is a far cry from a concentrated supplement. Since erdafitinib is serious cancer therapy, please run any hibiscus product by your oncology team or pharmacist first.
- Johnson SS, Oyelola FT, Ari T, Juho H. In vitro inhibitory activities of the extract of Hibiscus sabdariffa L. (family Malvaceae) on selected cytochrome P450 isoforms. Afr J Tradit Complement Altern Med. 2013 Apr 12;10(3):533-40.
What These Ratings Mean
Every interaction above is graded three ways — here’s the key to each label.
Clinically significant. Avoid the combination, or use only under close professional supervision.
Usually worth avoiding or managing — may need monitoring, a dose change, or timing apart.
Generally not serious. Be aware of it and mention it to your pharmacist.
- LikelyWell-controlled human studies have demonstrated the likely existence of this interaction.
- ProbableInteraction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- PossibleInteraction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
- UnlikelyInteraction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
- AHigh-quality meta-analysis (quantitative systematic review).
- BCase-control study.
- CConsensus.
- DAnecdotal evidence.
These ratings are for information only. Never start, stop, or otherwise change your therapy before speaking with your provider.
Hibiscus Sabdariffa Also Interacts With Other Medications
Hibiscus Sabdariffa has 2 major, 266 moderate, 818 minor known drug interactions in our database — the Erdafitinib one above is among them. If you take anything else, check it against the full list below.
Check Another of Your Medications Against Hibiscus Sabdariffa
We haven’t checked that one against Hibiscus Sabdariffa yet — ask our pharmacists directly.
Covers the 2,830 medications we’ve checked against Hibiscus Sabdariffa. Pick one to open its full report.
See Every Supplement That Interacts With Erdafitinib
This page covers Hibiscus Sabdariffa only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Erdafitinib page lists 169 supplements it has a documented interaction with, worst first, each one explained.
The most serious there right now: Activated Charcoal (major), Grapefruit (major), Phosphate Salts (major), St. John's Wort (major) and Acacia Rigidula (moderate).
By severity: 4 major · 127 moderate · 38 minor.
From our pharmacist’s overview on the Erdafitinib page
“Erdafitinib (Balversa) treats bladder cancers driven by FGFR gene changes, and its benefit depends on holding a steady drug level, so this is a list to be genuinely careful with. Four entries are rated major.”
Reviewed by 2 · Jul 18, 2026
Where Hibiscus Sabdariffa and Erdafitinib Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#481 of 1,452 supplements looked up here in the last 7 days
#2,069 of 2,830 medications looked up here in the last 7 days
Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.
About Hibiscus Sabdariffa
What is Hibiscus Sabdariffa?
- High blood pressure
- Heart and cholesterol health
- Digestive upset
- Antioxidant support
- Fever and general wellness
Hibiscus sabdariffa is a tart, cranberry-flavored plant most often consumed as a tea, and its best-studied use is for mildly lowering blood pressure. Evidence for other uses is limited, and while hibiscus tea is generally well tolerated in food amounts, concentrated supplements should be used cautiously and avoided in pregnancy. Talk to your pharmacist or doctor before using it for a medical condition.
About Erdafitinib
What Is Erdafitinib Used For?
Brand name: Balversa
Balversa (erdafitinib) is used to treat adults with locally advanced or metastatic urothelial carcinoma (UC) — cancer of the bladder or urinary tract — that has spread and has not responded to, or has gotten worse after, at least one prior round of systemic treatment. Patients must have a specific type of FGFR3 genetic alteration in their tumor, confirmed by an FDA-approved test before starting.
Balversa is not recommended for patients who are eligible for — but have not yet received — a PD-1 or PD-L1 inhibitor (a type of immunotherapy). Those therapies should be tried first when appropriate.
Other Drugs & Hibiscus Sabdariffa
Browse every other medication we’ve checked against Hibiscus Sabdariffa — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
2 interactions
266 interactions
- Diclofenac Sodium ›
- Diltiazem ›
- Nifedipine ›
- Insulin (rdna) ›
- Propranolol ›
- Hydrochlorothiazide ›
- Verapamil ›
- Glyburide ›
- Insulin (pork) ›
- Diclofenac Potassium ›
- Hydralazine ›
- Insulin (human) ›
- Trichlormethiazide ›
- Acarbose ›
- Bendroflumethiazide ›
- Insulin Glargine ›
- Lisinopril ›
- Metolazone ›
- Minoxidil ›
- Nicardipine ›
- Prazosin ›
- Semaglutide ›
- Spironolactone ›
- Timolol ›
- Acebutolol ›
- Acetazolamide ›
- Ambrisentan ›
- Amiloride ›
- Atenolol ›
- Betaxolol ›
- Candesartan Cilexetil ›
- Captopril ›
- Carteolol ›
- Carvedilol ›
- Chlorpropamide ›
- Chlorthalidone ›
- Cyclothiazide ›
- Diclofenac Epolamine ›
- Enalapril Maleate ›
- Exenatide ›
- Felodipine ›
- Glipizide ›
- Glucagon ›
- Guanethidine Monosulfate ›
- Iloprost ›
- Indapamide ›
- Insulin Lispro ›
- Irbesartan ›
- Labetalol ›
- Mannitol ›
- Metformin ›
- Methyclothiazide ›
- Methyldopa ›
- Metoprolol ›
- Nadolol ›
- Nebivolol ›
- Nimodipine ›
- Olmesartan Medoxomil ›
- Oxprenolol ›
- Pindolol ›
Showing 60 of 266 moderate interactions — see all 266 on the Hibiscus Sabdariffa page.
818 interactions
- Theophylline ›
- Ibuprofen ›
- Hydrocortisone ›
- Naproxen ›
- Erythromycin ›
- Estradiol ›
- Lidocaine ›
- Norethindrone ›
- Testosterone ›
- Levonorgestrel ›
- Prednisone ›
- Quinidine ›
- Cyclosporine ›
- Dexamethasone ›
- Triazolam ›
- Zopiclone ›
- Bupropion ›
- Colchicine ›
- Fentanyl ›
- Flurbiprofen ›
- Isotretinoin ›
- Orphenadrine ›
- Oxybutynin ›
- Oxycodone ›
- Phenytoin ›
- Prednisolone ›
- Tacrolimus ›
- Temazepam ›
- Budesonide ›
- Carbamazepine ›
- Clindamycin ›
- Dextromethorphan ›
- Doxorubicin ›
- Fluticasone ›
- Formoterol ›
- Indomethacin ›
- Miconazole ›
- Morphine Sulfate ›
- Trimipramine ›
- Acetaminophen ›
- Amphetamine ›
- Buprenorphine ›
- Conjugated Estrogens ›
- Diazepam ›
- Everolimus ›
- Ivabradine ›
- Lofepramine ›
- Medroxyprogesterone ›
- Medroxyprogesterone Acetate ›
- Meloxicam ›
- Nortriptyline ›
- Propoxyphene ›
- Rifampin ›
- Testosterone Undecanoate ›
- Tretinoin ›
- Aripiprazole ›
- Bendamustine ›
- Caffeine (otc Drug) ›
- Ciclesonide ›
- Clonazepam ›
Showing 60 of 818 minor interactions — see all 818 on the Hibiscus Sabdariffa page.
No interaction 1,743 drugs checked — show the list
We also checked Hibiscus Sabdariffa against these medications and found no known interaction in our sources. Open any page to confirm.
- Levothyroxine ›
- Methylphenidate ›
- Ivermectin ›
- Aspirin ›
- Rosuvastatin ›
- Escitalopram ›
- Docusate ›
- Valacyclovir ›
- Hydroxyurea ›
- Sumatriptan ›
- Amoxicillin ›
- Methotrexate ›
- Acyclovir ›
- Doxycycline ›
- Pregabalin ›
- Lamotrigine ›
- Azithromycin ›
- Gabapentin ›
- Methylene Blue ›
- Ciprofloxacin ›
- Levothyroxine, Liothyronine ›
- Cephalexin ›
- Cyclopentolate ›
- Roxithromycin ›
- Levetiracetam ›
- Pegunigalsidase Alfa-iwxj ›
- Ezetimibe ›
- Amoxicillin, Clavulanate Potassium ›
- Levothyroxine Sodium ›
- Dexmethylphenidate ›
- Daptomycin ›
- Phentermine, Topiramate ›
- Mitomycin ›
- Thyroid Hormone ›
- Hexobarbitone ›
- Carbidopa, Levodopa ›
- Factor 7a ›
- Hethylphenidate Hcl ›
- Levodopa ›
- Lenvatinib ›
- Azelaic Acid ›
- Cefaclor ›
- Phenylephrine ›
- Acetylsalicylic Acid ›
- Tenecteplase ›
- Pizotifen ›
- Hydroxychloroquine ›
- Bentoquatam ›
- Vancomycin ›
- Dirithromycin ›
- Ribavirin Aerosol ›
- Digoxin ›
- Triptorelin ›
- Pentobarbitone ›
- Dextrothyroxine ›
- Sodium Valproate ›
- Tocainide ›
- Rocuronium ›
- Procainamide ›
- Salbutamol Sulfate ›
Showing the 60 most looked-up of 1,743 medications checked with no known interaction — see the full Hibiscus Sabdariffa list.
Sources & How We Checked
Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference for vitamins, herbs and supplements — the basis for our interaction data.
- MedlinePlus, U.S. National Library of Medicine — NIH consumer drug information, used for the medication overviews.
- NIH Dietary Supplement Label Database (DSLD) — Official supplement product labels.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Taking Hibiscus Sabdariffa and Erdafitinib Together: Common Questions
Can you take Hibiscus Sabdariffa with Erdafitinib?
Why are there 2 interactions listed for Hibiscus Sabdariffa and Erdafitinib?
How serious is the Hibiscus Sabdariffa and Erdafitinib interaction?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Still Have a Question About Erdafitinib and Hibiscus Sabdariffa?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.